01.09.2020 | Case report
Fluticasone-propionate/mepolizumab/omalizumab
Lack of efficacy, anaphylaxis to excipient polysorbate-20 and cross reactivity: case report
Erschienen in: Reactions Weekly | Ausgabe 1/2020
Einloggen, um Zugang zu erhaltenExcerpt
Author Information-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event